financial CONCERNS
FAR-REACHING MPACTS
Financial toxicity can have far-reaching impacts on treatment adherence and the emotional well-being of the patient and the psychological and there are practical characteristics of financial toxicity that should be taken into account when working with patients struggling with this issue. To properly address financial toxicity, the financial navigator should have some basic understanding of the psychology behind the distress as well as understanding the many solutions available that help alleviate the cost burden for the patient. Some practical solutions include proactive engagement, insurance optimization, and optimization of external assistance programs.
The benefits of a financial navigation program are substantial. Not only can it reduce an individual patients' financial burden and increase profit margins, it can also alleviate patient distress, improve access to care, and improve patient satisfaction scores. As the statistical data related to financial toxicity in the oncology setting continue to grow, cancer programs should explore the current health of their financial advocacy program and evaluate if improvements are needed.
###
Patient Access Network (PAN) Foundation is pleased to announce that we are offering further support for Non-Small Cell Lung Cancer patients. By reopening this fund, PAN will continue to assist under-insured patients with the out-of-pocket costs associated with their medications. Patients diagnosed with Non-Small Cell Lung Cancer can now apply for assistance with PAN online, over the phone, through their specialty pharmacy or their provider’s office.
Qualified patients will be granted $7,500 annually to cover copayments, coinsurances, and deductibles. Patients who earn up to 400 percent of the Federal Poverty Level – $60,520 for a family of two – are eligible for assistance. Patients can apply for assistance online at www.PANfoundation.org or by calling 1-866-316-PANF (7263).
About PAN Foundation
PAN’s disease funds cover conditions such as multiple myeloma, metastatic breast cancer, and non-small cell lung cancer. PAN provides grants of $500 to $10,000 per year to qualified patients to help pay for medications for these diseases. Since 2004, PAN has provided more than $186 million in assistance for out-of-pocket expenses to more than 130,000 patients in need. Visit www.PANfoundation.org.
PAN Now Offering Financial Assistance to
Non-Small Cell Lung Cancer Patients
9